Abstract
Peer-reviewed publications using tobacco surveillance data represent a critical step toward evidence-based tobacco control, but research and publication capacity in countries with fewer resources may be limited. This paper describes patterns in use of the Global Adult Tobacco Survey (GATS) and/or Global Youth Tobacco Survey (GYTS) data for publications, investigates the origin of the data versus the origin of lead authorship, and describes geographic patterns of publications by country, region, and country income. A bibliometric inventory using six search engines was conducted for relevant studies using data from either of these surveys between January 1999 and January 2021. Descriptive statistics, including frequencies and percentages,were used to analyze publication characteristics. Our search strategy retrieved 1,834 initial records; 493 publications were ultimately included: 249 (50.5%) used adult surveillance data (GATS) and 248 (50.3%) used youth surveillance data (GYTS). Most publications were in English (97.2%, n=479). Data published 50 or more times represented 12 low- and middle-income countries (LMIC): India, Bangladesh, Vietnam, Mexico, Egypt, Thailand, Poland, Philippines, China, Russian Federation, Turkey and Ukraine. While many of the papers analyzed data from low- and middle-income countries, the number of publications by origin of lead author was the highest for the United States (n=135) and India (n=84). Over 80% of the world’s 1.3 billion tobacco users live in low- and middle-income countries (LMIC) and we found underrepresentation of these countries as lead authors. These findings can be used to identify opportunities to enhance capacity for analysis, research and dissemination of global tobacco control data in LMIC.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Partial financial support for this paper was provided by the CDC Foundation with a grant from Bloomberg Philanthropies.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos